Acetaminophen recommended as first-line drug therapy for osteoarthritis in ACR guidelines.
This article was originally published in The Tan Sheet
Executive Summary
ACETAMINOPHEN RECOMMENDED AS FIRST-LINE DRUG THERAPY FOR OSTEOARTHRITIS of the hip and knee in guidelines released on Oct. 23 by the American College of Rheumatology. The guidelines, the first of their kind, state that acetaminophen at doses of up to 4,000 mg/day is the recommended initial drug for systemic treatment of symptomatic osteoarthritis (OA) of the hip and knee.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning